{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:02Z","timestamp":1793600822847,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neuropharm.2026.110944","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:47:00Z","timestamp":1774338420000},"page":"110944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protective effects of adenosine A2B receptor antagonism in a cuprizone-induced demyelination model"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6742-456X","authenticated-orcid":false,"given":"Federica","family":"Cherchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Frulloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Panozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2736-9150","authenticated-orcid":false,"given":"Giada","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7521-3121","authenticated-orcid":false,"given":"Clara","family":"Santalmasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Maestrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-0420","authenticated-orcid":false,"given":"Maria Grazia","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Lana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110944_bib1","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1007\/s12035-023-03440-6","article-title":"Roles of adenosine receptor (subtypes A1 and A2A) in cuprizone-induced hippocampal demyelination","volume":"60","author":"Adebiyi","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: activation patterns of microglia and their identification in the human brain","volume":"39","author":"Boche","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110944_bib4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/ATVBAHA.112.252924","article-title":"Adenosine A2B Receptor Agonism Inhibits Neointimal Lesion Development After Arterial Injury in Apolipoprotein E\u2013Deficient Mice","volume":"32","author":"Bot","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.neuropharm.2026.110944_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12640-021-00331-3","article-title":"Cuprizone-dependent De\/Remyelination responses and functional correlates in mouse strains adopted to model relapsing, chronic and progressive experimental autoimmune encephalomyelitis","volume":"39","author":"Buonvicino","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2026.110944_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","article-title":"Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination","volume":"48","author":"Buschmann","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147277","article-title":"Ion channels as new attractive targets to improve Re-Myelination processes in the brain","volume":"22","author":"Cherchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib8","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4103\/1673-5374.306058","article-title":"Oligodendrocyte precursor cell maturation: role of adenosine receptors","volume":"16","author":"Cherchi","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2026.110944_bib9","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/glia.24593","article-title":"Adenosine A2B receptors differently modulate oligodendrogliogenesis and myelination depending on their cellular localization","volume":"72","author":"Cherchi","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.110944_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2013.02.005","article-title":"Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro","volume":"32","author":"Chhor","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.110944_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1113\/jphysiol.2004.074252","article-title":"NG2-positive cells in the mouse white and grey matter display distinct physiological properties","volume":"561","author":"Chittajallu","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249697","article-title":"A2B adenosine receptors: when outsiders may become an attractive target to treat brain ischemia or demyelination","volume":"21","author":"Coppi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.625662","article-title":"New insight into the role of adenosine in demyelination, stroke and neuropathic pain","volume":"11","author":"Coppi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2026.110944_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.621955","article-title":"Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System?","volume":"11","author":"D\u2019Antongiovanni","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.neuropharm.2026.110944_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.588757","article-title":"Protective Effect of Adenosine A2B Receptor Agonist, BAY60-6583, Against Transient Focal Brain Ischemia in Rat","volume":"11","author":"Dettori","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110944_bib17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2007-10-117044","article-title":"A2B adenosine receptor dampens hypoxia-induced vascular leak","volume":"111","author":"Eckle","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2026.110944_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.adc9020","article-title":"Molecular basis of astrocyte diversity and morphology across the CNS in health and disease","volume":"378","author":"Endo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110944_bib19","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1046\/j.1471-4159.1996.66041426.x","article-title":"Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells","volume":"66","author":"Fiebich","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110944_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn1928","article-title":"Purinergic signalling in neuron-glia interactions","volume":"7","author":"Fields","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2026.110944_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00399","article-title":"The selective antagonism of adenosine A2B receptors reduces the synaptic failure and neuronal death induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro","volume":"9","author":"Fusco","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2013.03.026","article-title":"Pleiotropic effect of histamine H4 receptor modulation in the central nervous system","volume":"71","author":"Galeotti","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110944_bib24","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1523\/JNEUROSCI.16-08-02659.1996","article-title":"Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block","volume":"16","author":"Gallo","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040945","article-title":"Delayed demyelination and impaired remyelination in aged mice in the cuprizone model","volume":"9","author":"Gingele","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.110944_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0076-6879(02)45035-5","article-title":"Double-label confocal microscopy of phosphorylated protein kinases involved in long-term potentiation","volume":"345","author":"Giovannini","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2009.06.005","article-title":"Regional differences between grey and white matter in cuprizone induced demyelination","volume":"1283","author":"Gudi","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110944_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroimage.2015.10.052","article-title":"Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination","volume":"125","author":"Guglielmetti","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2026.110944_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","article-title":"Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice","volume":"92","author":"Hiremath","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0165-5728(98)00168-4","article-title":"Microglial\/macrophage accumulation during cuprizone-induced demyelination in C57BL\/6 mice","volume":"92","author":"Hiremath","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101204","article-title":"Quantitative imaging of white and gray matter remyelination in the cuprizone demyelination model using the macromolecular Proton fraction","volume":"8","author":"Khodanovich","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.110944_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1083\/jcb.26.1.157","article-title":"Localization of a basic protein in the myelin of various species with the aid of fluorescence and electron microscopy","volume":"26","author":"Kornguth","year":"1965","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.1101224","article-title":"Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process","volume":"188","author":"Koscs\u00f3","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1742-2094-11-109","article-title":"CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system","volume":"11","author":"Krauthausen","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110944_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.115.4.777","article-title":"The encephalomyelitic activity of myelin isolated by ultracentrifugation","volume":"115","author":"Laatsch","year":"1962","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2026.110944_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813668","article-title":"Phenomic microglia diversity as a druggable target in the hippocampus in neurodegenerative diseases","volume":"24","author":"Lana","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00322","article-title":"The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole","volume":"6","author":"Lana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1451114","article-title":"Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP\/PS1 transgenic mouse model","volume":"15","author":"Lana","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/ph14050485","article-title":"Synthesis of novel fluorinated xanthine derivatives with high adenosine A2B receptor binding affinity","volume":"14","author":"Lindemann","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2026.110944_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22593","article-title":"Olesoxime accelerates myelination and promotes repair in models of demyelination","volume":"71","author":"Magalon","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib42","doi-asserted-by":"crossref","first-page":"15771","DOI":"10.1096\/fj.202000939R","article-title":"Adenosine A2B receptor: a pathogenic factor and a therapeutic target for sensorineural hearing loss","volume":"34","author":"Manalo","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.110944_bib43","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0002-9440(10)63726-1","article-title":"Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions","volume":"164","author":"Mason","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib45","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1096\/fj.15-275503","article-title":"Clasmatodendrosis and b-amyloidosis in aging hippocampus","volume":"30","author":"Mercatelli","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.110944_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2016.11.024","article-title":"A2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway","volume":"117","author":"Merighi","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2026.110944_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2015.11.007","article-title":"Purinergic signalling in brain ischemia","volume":"104","author":"Pedata","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110944_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1596469","article-title":"Chronic administration of prebiotics and probiotics prevent pathophysiological hallmarks of Alzheimer's disease in the cortex of APP\/PS1 mice","volume":"16","author":"Sarti","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2005.12.005","article-title":"Microglial phenotype: is the commitment reversible?","volume":"29","author":"Schwartz","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110944_bib50","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/glia.24148","article-title":"The roles of microglia and astrocytes in phagocytosis and myelination: insights from the cuprizone model of multiple sclerosis","volume":"70","author":"Sen","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.110944_bib51","first-page":"1585","article-title":"De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected","volume":"26","author":"Skripuletz","year":"2011","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib52","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2008.070850","article-title":"Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent","volume":"172","author":"Skripuletz","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0896-6273(02)01067-X","article-title":"Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials","volume":"36","author":"Stevens","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110944_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(98)00223-4","article-title":"Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and\/or anxiolytic state in mice","volume":"350","author":"Takeda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/jnc.12289","article-title":"Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination","volume":"127","author":"Tanaka","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.110944_bib56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1248\/bpb.b19-00976","article-title":"Involvement of A2B receptor in DNA damage response and radiosensitizing effect of A2B receptor antagonists on mouse B16 Melanoma","volume":"43","author":"Tanaka","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2026.110944_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-024-07611-w","article-title":"Adenosine signalling to astrocytes coordinates brain metabolism and function","volume":"632","author":"Theparambil","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110944_bib58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jcb.21611","article-title":"Short-term TNF-Alpha treatment induced A2B adenosine receptor desensitization in human astroglial cells","volume":"104","author":"Trincavelli","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2026.110944_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1570159X15666170717120343","article-title":"Five decades of cuprizone, an updated model to replicate demyelinating diseases","volume":"17","author":"Vega-Riquer","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4049\/jimmunol.1103721","article-title":"Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation","volume":"190","author":"Wei","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2026.110944_bib61","article-title":"Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110944_bib62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jnr.10368","article-title":"Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies","volume":"70","author":"Yuan","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2026.110944_bib63","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular Architecture of the mouse nervous System","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110944_bib64","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1021\/acs.jafc.0c04604","article-title":"Cuprizone-Induced demyelination in mouse hippocampus is alleviated by ketogenic diet","volume":"68","author":"Zhang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2026.110944_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00538-8","article-title":"Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination","volume":"17","author":"Zirngibl","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110944_bib66","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/glia.22511","article-title":"Alterations of juxtaparanodal domains in two rodent models of CNS demyelination","volume":"61","author":"Zoupi","year":"2013","journal-title":"Glia"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:34:17Z","timestamp":1793597657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"alternative-id":["S0028390826001176"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110944","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of adenosine A2B receptor antagonism in a cuprizone-induced demyelination model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110944"}}